Latest events and quotes from media sources around the world related
to Diamyd Medical and diabetes research. Diamyd Medical is a diabetes
company headquartered in Stockholm, Sweden. The Company develops the
diabetes vaccine Diamyd®, which has the potential to become a key
piece of the puzzle of a future solution to prevent, treat or cure
type 1 diabetes and other forms of diabetes. Articles presented in
this feed are not press releases and may include excerpts from and
links to externally published content. Diamyd Medical is not
responsible for externally published content.
